[1]
Chen, C.; Chai, X.; Hu, X.; Lou, S.; Li, D.; Hou, T. Cui, S. Discovery of 2-(1-(3-Chloro-4-cyanophenyl)-1H-pyrazol-3-yl) acetamides as potent, selective, and orally available antagonists targeting the androgen receptor. J. Med. Chem., 2022, 65, 13074-13093.
[2]
Qi, J.; Wang, W.; Tang, Y.; Lou, S.; Wang, J.; Yuan, T.; He, Q.; Yang, B.; Zhu, H. Cui, S. Discovery of novel indazoles as potent and selective PI3K δ inhibitors with high efficacy for treatment of hepatocellular carcinoma. J. Med. Chem., 2022, 65, 3849-3865.
[3]
Zeng, L.; Li, J. Cui, S. Rhodium-catalyzed atroposelective click cycloaddition of azides and alkynes. Angew. Chem. Int. Ed., 2022, 61, e202205037.
Related Journals
Current Pharmaceutical Design
Current Topics in Medicinal Chemistry
Current Respiratory Medicine Reviews
Infectious Disorders - Drug Targets
Endocrine, Metabolic & Immune Disorders - Drug Targets
Anti-Infective Agents
Coronaviruses
Recent Advances in Inflammation & Allergy Drug Discovery
Current Probiotics
